A. Sanders
Director/Board Member chez BIOCRYST PHARMACEUTICALS, INC.
Fortune : 130 129 $ au 31/03/2024
Profil
A.
Machelle Sanders is an Independent Director at BioCryst Pharmaceuticals, Inc. and the Secretary at The North Carolina Department of Commerce.
She previously served as an Independent Director at Radius Health, Inc., NVN Liquidation, Inc., and the North Carolina Department of Administration.
She was also the Director at The North Carolina Biotechnology Center and the Vice President-Manufacturing & General Manager at Biogen, Inc. Ms. Sanders holds an undergraduate degree from North Carolina State University and a graduate degree from Pfeiffer University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2023 | 25 611 ( 0,01% ) | 130 104 $ | 31/03/2024 | |
NVN LIQUIDATION INC
0,09% | 27/06/2023 | 25 248 ( 0,09% ) | 25 $ | 31/03/2024 |
Postes actifs de A. Sanders
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 08/02/2022 |
| The North Carolina Department of Commerce | Corporate Secretary | 01/02/2021 |
Anciens postes connus de A. Sanders
| Sociétés | Poste | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Director/Board Member | 27/09/2023 |
| RADIUS HEALTH, INC. | Director/Board Member | 15/08/2022 |
| North Carolina Department of Administration | Corporate Secretary | 01/02/2021 |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01/01/2015 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2015 |
Formation de A. Sanders
| North Carolina State University | Undergraduate Degree |
| Pfeiffer University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| NVN LIQUIDATION, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
| The North Carolina Department of Commerce | Government |
| North Carolina Department of Administration | Government |
| Research Triangle Park |
